Effects of Ursolic Acid Derivatives on Caco-2 Cells and Their Alleviating Role in Streptozocin-Induced Type 2 Diabetic Rats

被引:24
作者
Wu, Panpan [1 ]
He, Ping [1 ]
Zhao, Suqing [1 ]
Huang, Tianming [1 ]
Lu, Yujing [1 ]
Zhang, Kun [1 ]
机构
[1] Guangdong Univ Technol, Fac Chem Engn & Light Ind, Dept Pharmaceut Engn, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetes mellitus; ursolic acid derivatives; Caco-2; cell; 2-NBDG; streptozotocin (STZ)-induced diabetic rat; GLUCOSE-UPTAKE; ANTIDIABETIC ACTIVITY; OXIDATIVE STRESS; FREE-RADICALS; LIFE-STYLE; INSULIN; ABSORPTION; MODEL; LINE; HYPERLIPIDEMIA;
D O I
10.3390/molecules190812559
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, the effect and mechanism of a series of ursolic acid (UA) derivatives on glucose uptake were investigated in a Caco-2 cells model. Their effect on hyperglycemia, hyperlipidemia and oxidative stress were also demonstrated in streptozocin (STZ)-induced diabetic rats. 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) was used as a fluorescein in Caco-2 cells model to screen UA derivatives by glucose uptake and expression of glucose transporter protein (SGLT-1, GLUT-2). Moreover, STZ-induced diabetic rats were administered with these derivatives for 4 weeks of treatment. The fasting blood glucose (FBG), insulin levels, biochemical parameters, lipid levels, and oxidative stress markers were finally evaluated. The results of this study indicated that compounds 10 and 11 significantly inhibited 2-NBDG uptake under both Na+-dependent and Na+-independent conditions by decreasing SGLT-1 and GLUT-2 expression in the Caco-2 cells model. Further in vivo studies revealed that compound 10 significantly reduced hyperglycemia by increasing levels of serum insulin, total protein, and albumin, while the fasting blood glucose, body weight and food intake were restored much closer to those of normal rats. Compounds 10 and 11 showed hypolipidemic activity by decreasing the total amounts of cholesterol (TC) and triglycerides (TG). Furthermore, compound 10 showed antioxidant potential which was confirmed by elevation of glutathione (GSH) and superoxide dismutase (SOD) and reduction of malondialdehyde (MDA) levels in the liver and kidney of diabetic rats. It was concluded that compound 10 caused an apparent inhibition of intestinal glucose uptake in Caco-2 cells and hypoglycemia, hypolipidemia and augmented oxidative stress in STZ-induced diabetic rats. Thus, compound 10 could be developed as a potentially complementary therapeutic or prophylactic agent for diabetics mellitus and its complications.
引用
收藏
页码:12559 / 12576
页数:18
相关论文
共 56 条
[1]   STRICT INSULIN THERAPY NORMALIZES ORGAN NITROGEN CONTENTS AND THE CAPACITY OF UREA NITROGEN SYNTHESIS IN EXPERIMENTAL DIABETES IN RATS [J].
ALMDAL, TP ;
VILSTRUP, H .
DIABETOLOGIA, 1988, 31 (02) :114-118
[2]   Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats [J].
Arya, Aditya ;
Looi, Chung Yeng ;
Cheah, Shiau Chuen ;
Mustafa, Mohd Rais ;
Mohd, Mustafa Ali .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 144 (01) :22-32
[3]   Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia [J].
Baldea, Lidia A. Nistor ;
Martineau, Louis C. ;
Benhaddou-Andaloussi, Ali ;
Amason, John T. ;
Levy, Emile ;
Haddad, Pierre S. .
JOURNAL OF ETHNOPHARMACOLOGY, 2010, 132 (02) :473-482
[4]   Topical anti-inflammatory activity of Salvia officinalis L. leaves:: the relevance of ursolic acid [J].
Baricevic, D ;
Sosa, S ;
Della Loggia, R ;
Tubaro, A ;
Simonovska, B ;
Krasna, A ;
Zupancic, A .
JOURNAL OF ETHNOPHARMACOLOGY, 2001, 75 (2-3) :125-132
[5]   FREE-RADICALS IN BIOLOGICAL-SYSTEMS - A REVIEW ORIENTATED TO INFLAMMATORY PROCESSES [J].
BLAKE, DR ;
ALLEN, RE ;
LUNEC, J .
BRITISH MEDICAL BULLETIN, 1987, 43 (02) :371-385
[6]   Glucose transporters: Structure, function and consequences of deficiency [J].
Brown, GK .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (03) :237-246
[7]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[8]   Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk [J].
Carr, MC ;
Brunzell, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2601-2607
[9]   Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats [J].
Cemek, Mustafa ;
Kaga, Sadik ;
Simsek, Nejdet ;
Buyukokuroglu, Mehmet Emin ;
Konuk, Muhsin .
JOURNAL OF NATURAL MEDICINES, 2008, 62 (03) :284-293
[10]  
Delie F, 1997, CRIT REV THER DRUG, V14, P221